Zinc compounds, a new treatment in peptic ulcer.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 2661183)

Published in Drugs Exp Clin Res on January 01, 1989

Authors

G Escolar1, O Bulbena

Author Affiliations

1: Department of Pharmacology, Laboratorios Viñas S.A., Barcelona, Spain.

Articles by these authors

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology (1993) 1.61

Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology (1997) 1.59

Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy (2003) 1.53

Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination. Gastroenterology (1992) 1.49

Cyclooxygenase and lipoxygenase metabolism in sodium taurocholate induced acute hemorrhagic pancreatitis in rats. Prostaglandins (1993) 1.46

Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. Prostaglandins (1991) 1.39

In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol (2003) 1.07

Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation (2002) 1.04

Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis. Thorax (2006) 0.99

Oxidised lipids present in ascitic fluid interfere with the regulation of the macrophages during acute pancreatitis, promoting an exacerbation of the inflammatory response. Gut (2008) 0.98

Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am Rev Respir Dis (1992) 0.98

P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax (2002) 0.89

Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Crit Care Med (2003) 0.87

Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation (2000) 0.84

Differential activity of nitric oxide synthase in human nasal mucosa and polyps. Eur Respir J (1996) 0.83

Xanthine oxidase activation in cerulein- and taurocholate-induced acute pancreatitis in rats. Arch Int Physiol Biochim Biophys (1995) 0.83

Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Dig Dis Sci (1998) 0.82

15-Hydroxyeicosatetraenoic acid as a major eicosanoid in nasal secretions: assay by high-performance liquid chromatographic-radioimmunoassay and gas chromatographic-mass spectrometric procedures. J Chromatogr (1989) 0.81

Simultaneous reversed-phase extraction of lipoxygenase and cyclooxygenase metabolites of arachidonic acid in nasal secretions: methodological aspects. J Chromatogr (1990) 0.81

In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. Prostaglandins (1991) 0.80

Modern high-performance liquid chromatographic-radioimmunoassay strategies for the study of eicosanoids in biological samples. J Chromatogr (1989) 0.80

Effects of omega-toxins on noradrenergic neurotransmission in beating guinea pig atria. Eur J Pharmacol (1995) 0.80

Effects of zinc acexamate on gastric mucosal resistance factors. Eur J Pharmacol (1985) 0.80

Permeation by zinc of bovine chromaffin cell calcium channels: relevance to secretion. Pflugers Arch (1994) 0.79

Prostanoid generation in early stages of acute pancreatitis: a role for nitric oxide. Inflammation (1994) 0.79

Thermospray liquid chromatography/mass spectrometry of prostaglandin methyl ester derivatives: application to the determination of prostaglandins E2 and D2 in rat gastric mucosa. Biomed Environ Mass Spectrom (1988) 0.79

Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. Transplantation (1995) 0.79

Anti-ulcer and membrane stabilizing actions of zinc acexamate. Arch Int Pharmacodyn Ther (1987) 0.79

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia. Eur Respir J (2009) 0.78

Effect of cold-restraint stress and zinc acexamate on gastric mucus production in intact glands. Arch Int Pharmacodyn Ther (1987) 0.78

Effect of zinc acexamate and ranitidine on chronic gastric lesions in the rat. Digestion (1990) 0.78

Constitutive nuclear factor-kappaB activity in human upper airway tissues and nasal epithelial cells. Eur Respir J (2000) 0.78

Prostanoids and oxygen free radicals in early stages of experimental acute pancreatitis. Dig Dis Sci (1994) 0.78

Zinc compounds as therapeutic agents in peptic ulcer. Methods Find Exp Clin Pharmacol (1989) 0.78

Gastrotoxic activity and inhibitory effects on gastric mucosal PGE2 production with different non-steroidal anti-inflammatory drugs: modifications induced by pretreatment with zinc acexamate. Prostaglandins Leukot Essent Fatty Acids (1994) 0.78

Metabolism of N-phenyllinoleamide by rat liver. J Chromatogr (1993) 0.77

Mass spectrometric identification of N-phenyllinoleamide metabolites in mouse peritoneal macrophages. Rapid Commun Mass Spectrom (1995) 0.77

N-phenyllinoleamide metabolism by human polymorphonuclear leukocytes. Xenobiotica (1994) 0.77

Cyclooxygenase and lipoxygenase arachidonate metabolites synthesized by mouse peritoneal macrophages: in vitro effect of N-phenyllinoleamide from toxic oil samples. Agents Actions (1993) 0.77

Arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. J Lipid Mediat Cell Signal (1994) 0.77

Effect of prostaglandins and superoxide dismutase administration on oxygen free radical production in experimental acute pancreatitis. Inflammation (1993) 0.76

Oxidative metabolism of N-phenyllinoleamide by human nasal polyps. Prostaglandins (1992) 0.75

Pancreas prostanoid production in ischemia and reperfusion. Prostaglandins (1992) 0.75

Recovery of nasal prostaglandin production after inhibition by aspirin. Prostaglandins Leukot Essent Fatty Acids (1990) 0.75

Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. Dig Dis Sci (1993) 0.75

[NMR determination of the conformation of adrenaline in a complex with Mg2+ and ATP]. Arch Farmacol Toxicol (1979) 0.75

Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. Transplantation (1994) 0.75

Urinary prostanoids excretion in kidney transplantation: its relationship to acute rejection and cyclosporine-induced nephrotoxicity. Transplant Proc (1994) 0.75

Induction of c-fos messenger RNA by 3-(N-phenylamino)-1,2-propanediol esters, compounds related to Toxic Oil Syndrome. Chem Biol Interact (2004) 0.75

[Variations in the conformation of adrenaline as a function of pH]. Arch Farmacol Toxicol (1979) 0.75

Prostaglandin levels in infertile patients affected by asthenozoospermia and prostatitis. Prostaglandins Leukot Essent Fatty Acids (1988) 0.75

[1H NMR study of the conformation of adrenaline in the presence of Na+ and K+ ions]. Arch Farmacol Toxicol (1979) 0.75

Zinc acexamate reduces gastric damage induced by platelet-activating factor. Prostaglandins Leukot Essent Fatty Acids (1989) 0.75

[Nitric oxide synthase activity in nasal mucosa]. Acta Otorrinolaringol Esp (1998) 0.75

Prostaglandin E2 and thromboxane B2 levels in rats subjected to pancreas transplantation. Prostaglandins (1990) 0.75

Relationship between gastric levels and antiulcerogenic activity of zinc. Arch Int Pharmacodyn Ther (1991) 0.75

Cytoprotective and antisecretory activity of a ranitidine-zinc complex. Prostaglandins Leukot Essent Fatty Acids (1995) 0.75

Antiulcerogenic activity of zinc acexamate in different experimental models. Methods Find Exp Clin Pharmacol (1987) 0.75

[Comparison of various methods for the study of noradrenaline fixation to proteins]. Arch Farmacol Toxicol (1977) 0.75

Gas chromatographic/mass spectrometric analysis of high-performance liquid chromatographic fractions reflecting arachidonic acid metabolism in mouse peritoneal macrophages. Biol Mass Spectrom (1992) 0.75

Application of liquid radiochromatographic techniques to the metabolic profiling of xenobiotically-mediated arachidonate metabolism. J Pharm Biomed Anal (1991) 0.75

Pancreas lipoxygenase arachidonic acid metabolites production in streptozotocin-induced diabetes in rats. Horm Metab Res (1994) 0.75

Prostaglandin PGE2 and PGF2alpha levels in nasal secretions from healthy subjects by liquid chromatography and radioimmunological assay. J Pharm Biomed Anal (1988) 0.75

Effect of zinc acexamate on gastric lesions induced by aspirin: a morphological study. Eur J Pharmacol (1990) 0.75

Effects of zinc acexamate on gastric mucosal production of prostaglandin E2 in normal and stressed rats. Prostaglandins Leukot Essent Fatty Acids (1988) 0.75

Determination of oxidation products of N-phenyllinoleamide: Spanish toxic oil syndrome studies. J Chromatogr (1988) 0.75

Cyclooxygenase products of metabolism of arachidonic acid in mouse macrophages exposed to N-phenyllinoleamide from toxic oil samples. Prostaglandins Leukot Essent Fatty Acids (1990) 0.75

Gastrointestinal surface changes: interpretation problems and indexing possibilities (a review). Scanning Microsc (1989) 0.75

Transmucosal potential difference in experimental colitis in rats. Inflammation (1995) 0.75

Calcium channel blockers in experimental acute pancreatitis: effect on tissue prostanoids and oxygen free radicals. Pancreas (1996) 0.75

[Protection by zinc acexamate against gastric lesions induced by non-steroid anti-inflammatory agents]. Rev Esp Enferm Dig (1993) 0.75

Influence of N-phenyllinoleamide from toxic oil samples on the lipoxygenase metabolism of exogenous arachidonic acid in mouse peritoneal macrophages. Prostaglandins Leukot Essent Fatty Acids (1992) 0.75

Morphological study of gastric lesions developing in the rat under several damaging conditions: modifications induced by pretreatment with zinc acexamate. Scanning Microsc (1992) 0.75

Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.75

[Effects of zinc acexamate on blood flow in the gastric mucosa of the rat]. Rev Esp Enferm Apar Dig (1988) 0.75

Application of totally automated on-line sample clean up system for extraction and high-performance liquid chromatography separation of peptide leukotrienes. J Pharm Biomed Anal (1994) 0.75